metastatic pancreatic adenocarcinoma

Showing 1 - 25 of 71

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Colorectal Adenocarcinoma, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

Not yet recruiting
  • Metastatic Colorectal Adenocarcinoma
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 12, 2023

Metastatic Pancreatic Adenocarcinoma Trial in Shanghai (Ascorbate, Nab paclitaxel, Gemcitabine)

Recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Shanghai, Shanghai, China
    Shanghai Cancer Center
Aug 29, 2023

Metastatic Pancreatic Adenocarcinoma Trial in Ann Arbor (Devimistat, Modified FOLFIRINOX)

Not yet recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Ann Arbor, Michigan
    Rogel Cancer Center
Jun 26, 2023

Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Trial in Canada,

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +5 more
  • Anetumab Ravtansine
  • +5 more
  • Birmingham, Alabama
  • +44 more
Feb 2, 2023

Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in Worldwide (zolbetuximab,

Recruiting
  • Pancreatic Cancer
  • +2 more
  • Goodyear, Arizona
  • +131 more
Jan 30, 2023

Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in United States (Olaparib, Pembrolizumab)

Recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Stage IV Pancreatic Cancer AJCC v8
  • Anchorage, Alaska
  • +513 more
Jan 28, 2023

Metastatic Pancreatic Adenocarcinoma Trial in Worldwide (Irinotecan liposome injection, Folinic Acid, 5-Fluorouracil)

Recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Irinotecan liposome injection
  • +2 more
  • Bedford Park, Australia
  • +35 more
Jan 24, 2023

Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma Trial in Bethesda, Boston (Biopsy,

Recruiting
  • Advanced Fallopian Tube Carcinoma
  • +21 more
  • Biopsy
  • +2 more
  • Bethesda, Maryland
  • +2 more
Jan 25, 2023

Metastatic Pancreatic Adenocarcinoma Trial (Avelumab and Pepinemab)

Recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Avelumab and Pepinemab
  • Rochester, New York
    University of Rochester Medical Center
Jan 19, 2023

Colorectal Adenocarcinoma, Gastric Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Atlanta (Nanoliposomal

Recruiting
  • Colorectal Adenocarcinoma
  • +13 more
  • Nanoliposomal Irinotecan
  • Trifluridine and Tipiracil Hydrochloride
  • Atlanta, Georgia
  • +2 more
Jan 6, 2023

Metastatic Pancreatic Adenocarcinoma Trial in Baltimore (Epacadostat, Pembrolizumab, CRS-207)

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 3, 2023

Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +24 more
  • 18F-Fluoromisonidazole
  • +4 more
  • La Jolla, California
  • +15 more
Jan 3, 2023

Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in New

Recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • +12 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 30, 2022

Pancreas Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in Boston (drug, radiation, procedure)

Recruiting
  • Pancreas Cancer
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Aug 19, 2022

Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in United States (Gemcitabine combined with

Recruiting
  • Metastatic Pancreatic Cancer
  • Metastatic Pancreatic Adenocarcinoma
  • Gemcitabine combined with nab-paclitaxel
  • +4 more
  • La Jolla, California
  • +20 more
Aug 18, 2022

Extrahepatic Bile Duct Adenocarcinoma, Biliary Type, Gallbladder Adenocarcinoma, Biliary Type, Metastatic Pancreatic

Active, not recruiting
  • Extrahepatic Bile Duct Adenocarcinoma, Biliary Type
  • +27 more
  • Los Angeles, California
  • +2 more
Aug 5, 2022

Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma, Non-Resectable Cholangiocarcinoma Trial in Los

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +15 more
  • Los Angeles, California
  • +1 more
Aug 5, 2022

Metastatic Pancreatic Adenocarcinoma Trial in United States (Nivolumab (Cohort A), Ipilimumab (Cohort A and B),

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Nivolumab (Cohort A)
  • +4 more
  • Los Angeles, California
  • +6 more
Aug 8, 2022

Metastatic Pancreatic Adenocarcinoma Trial (odetiglucan, CDX-1140)

Not yet recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • odetiglucan
  • CDX-1140
  • (no location specified)
Jul 29, 2022

Colorectal Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Recurrent Colorectal Carcinoma Trial in Atlanta (XL888,

Active, not recruiting
  • Colorectal Adenocarcinoma
  • +14 more
  • Atlanta, Georgia
  • +2 more
Jul 5, 2022

Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma Trial in

Active, not recruiting
  • Locally Advanced Pancreatic Adenocarcinoma
  • +4 more
  • Biopsy
  • +4 more
  • Chicago, Illinois
  • +11 more
Jun 28, 2022

Metastatic Pancreatic Adenocarcinoma Trial in Cleveland (Regorafenib, Gemcitabine Hydrochloride)

Terminated
  • Metastatic Pancreatic Adenocarcinoma
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jun 1, 2022

Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in United States (Fluorouracil, Gemcitabine,

Recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Stage IV Pancreatic Cancer AJCC v8
  • Boise, Idaho
  • +42 more
Jun 8, 2022

Locally Advanced Malignant Solid Tumor, Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in United

Recruiting
  • Locally Advanced Malignant Solid Neoplasm
  • +3 more
  • Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949
  • VLP-encapsulated TLR9 Agonist CMP-001
  • Scottsdale, Arizona
  • +3 more
Jun 1, 2022